This compound is a pharmaceutical intermediate featuring a cyclobutane-diamine core substituted with a methyl group and a pyrrolopyrimidine heterocyclic ring. It is primarily used as a building block in the synthesis of active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1622980-99-7
Despropanesulfonyl Abrocitinib
Pharmaceutical intermediate for abrocitinib
2-acetyl-2-azabicyclo[2.2.1]hept-5-en-3-one
Abacavir impurity intermediate
Bis(2-(7-methoxynaphthalen-1-yl)ethyl)aminehydrochloride
Agomelatine impurity reference standard
2,4-Dichlorothieno[3,2-d]pyrimidine
Pharmaceutical intermediate
2-Acetamido-2-(4-octylphenethyl)propane-1,3-diyl diacetate
pharmaceutical intermediate
(1s,3s)-N-hydroxy-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclobutanecarboxamide
research compound for kinase inhibition
N-(cis-3-(Methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)-1-propanesulfonamide
Janus kinase inhibitor
1-N-methyl-1-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)cyclobutane-1,3-diamine
DSZFXAFWOBUIFN-UHFFFAOYSA-N
CN(C1CC(C1)N)C2=NC=NC3=C2C=CN3
—